CLK1/SRSF5 pathway induces aberrant exon skipping of METTL14 and Cyclin L2 and promotes growth and metastasis of pancreatic cancer

MLA

Jiaqiang Zhang, et al. “CLK1/SRSF5 Pathway Induces Aberrant Exon Skipping of METTL14 and Cyclin L2 and Promotes Growth and Metastasis of Pancreatic Cancer.” Journal of Hematology & Oncology, vol. 14, Apr. 2021. EBSCOhost, https://doi.org/10.1186/s13045-021-01072-8.

APA

Jiaqiang Zhang, Jiang-Zhi Chen, Yao-Dong Wang, Qian Zhan, Yi Huang, Long Huang, Jing-Jing Pan, Zu-Wei Wang, Cheng-Yu Liao, Can Yang, Shi Chen, Baiyong Shen, Yifeng Tian, & Jian-Fei Hu. (2021). CLK1/SRSF5 pathway induces aberrant exon skipping of METTL14 and Cyclin L2 and promotes growth and metastasis of pancreatic cancer. Journal of Hematology & Oncology, 14. https://doi.org/10.1186/s13045-021-01072-8

Chicago

Jiaqiang Zhang, Jiang-Zhi Chen, Yao-Dong Wang, Qian Zhan, Yi Huang, Long Huang, Jing-Jing Pan, et al. 2021. “CLK1/SRSF5 Pathway Induces Aberrant Exon Skipping of METTL14 and Cyclin L2 and Promotes Growth and Metastasis of Pancreatic Cancer.” Journal of Hematology & Oncology 14 (April). doi:10.1186/s13045-021-01072-8.